Weihong Zhou

1.3k citations
53 papers · 1.0k indexed · h-index 20
Topics
Pharmacogenetics and Drug Metabolism (14 papers)Enzyme Structure and Function (8 papers)Computational Drug Discovery Methods (7 papers)

In The Last Decade

Weihong Zhou

50 papers receiving 1.0k citations

Peers

Weihong Zhou
Comparison fields: 5 of 128
  • Molecular Biology 474
  • Pharmacology 342
  • Inorganic Chemistry 178
  • Materials Chemistry 129
  • Oncology 95
Replace Yosephine Gumulya with:
Yosephine Gumulya Australia
Hong Lin Zhai China
Beibei Wang China
John A. McIntosh United States
Cristina Fernández Spain
Lizhi Zhu China
Frank Baganz United Kingdom
Lijing Yang China
Lisa M. Newman United States
Abhisek Banerjee India
Weihong Zhou relative to Yosephine Gumulya Australia Yosephine Gumulya's profile →
Citations per field
00.5×4.3×
Yosephine Gumulya · 1×
Citations per year

Countries citing papers authored by Weihong Zhou

Since Specialization
Citations

This map shows the geographic impact of Weihong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihong Zhou more than expected).

Fields of papers citing papers by Weihong Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihong Zhou. The network helps show where Weihong Zhou may publish in the future.

Co-authorship network of co-authors of Weihong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weihong Zhou. A scholar is included among the top collaborators of Weihong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihong Zhou. Weihong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 5
5 1
6 6
7 2
8 1
9 22
10 59
11 26
12 54
13 10
14 42
15 2
16 32
17 31
18 40
19 1
20 3

About Weihong Zhou

Weihong Zhou is a scholar working on Pharmacology, General Engineering and Inorganic Chemistry, having authored 53 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (14 papers), Enzyme Structure and Function (8 papers) and Computational Drug Discovery Methods (7 papers). The work is most often cited by research in Pharmacology (342 citations), Inorganic Chemistry (178 citations) and Molecular Biology (474 citations). Weihong Zhou has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Luet‐Lok Wong, Stephen G. Bell, Wen Yang, Zihe Rao, Mark Bartlam, Jake A. Yorke, Ting Zhang, Ruimin Zhou, Hui Wang and Xinkun Ren. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026